Celularity (CELU)
Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through t...
- Open
- 0.7700
- High
- 0.8500
- Low
- 0.7305
- Prev. Close
- 0.7670
- Volume
- 26.35K
- Turnover
- 21.15K
- Avg Price
- 0.8027
- Bid/Ask Ratio
- --
- Amplitude
- 15.58%
- 52wk High
- 4.0100
- Volume Ratio
- 0.67
- Turnover Ratio
- 0.14%
Celularity Analyst Rating
View moreForecast & Rating
Jun 22, 2023Price forecast
$25.003025.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Aug 18 at 01:00 AM
Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition
- PUBT · Jul 29 at 03:36 PM
Celularity risks Nasdaq delisting after CELU bid price stays below $1 for 30 days
- benzinga_article · Jul 6 at 04:05 PM
12 Health Care Stocks Moving In Monday's After-Market Session
- Tip Ranks · Jun 30 at 08:41 AM
Celularity Secures Insider-Backed Short-Term Loan Facility
- PUBT · Jun 30 at 08:02 AM
Celularity enters USD 1 million secured loan deal with Barach Family Trust
- TradingView · Jun 25 at 04:33 PM
Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary
